Primary osteolysis
MONDO:00197075 clinical trials for this condition and its sub-types, 0 tagged with Primary osteolysis itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Part of
Sub-types of Primary osteolysis
-
Hutchinson-Gilford progeria syndrome 3 trials
-
Hyaline fibromatosis syndrome 1 trial · 2 incl. sub-types
2 sub-types
- Infantile systemic hyalinosis 1 trial
- Juvenile hyaline fibromatosis 0 trials
-
Nestor-Guillermo progeria syndrome 0 trials
-
Paget disease of bone 2, early-onset 0 trials
-
Acroosteolysis 0 trials
1 sub-type
- Acroosteolysis dominant type 0 trials
-
Familial expansile osteolysis 0 trials
-
Mandibuloacral dysplasia 0 trials
2 sub-types
-
2 sub-types
- Winchester syndrome 0 trials
- Multicentric osteolysis, nodulosis, and arthropathy 0 trials
-
Pacman dysplasia 0 trials
-
Phalangeal microgeodic syndrome 0 trials
-
Talo-patello-scaphoid osteolysis 0 trials
-
New drug combo aims to slow Progeria's effects
Disease control By invitation onlyThis study tests whether adding everolimus to the existing drug lonafarnib can better control progeria, a rare disease that causes rapid aging in children. About 80 children with confirmed progeria will take both pills by mouth. The first part finds the safest dose of everolimus,…
Phase 1/2 • Sponsor: Boston Children's Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:03 UTC
-
New hope for kids with rapid-aging disease: drug combo tested
Disease control OngoingThis study tests a new drug called progerinin, given together with the standard medicine lonafarnib, in 10 children with Hutchinson-Gilford progeria syndrome (a rare disease that causes rapid aging). The goal is to find the best dose and check if the combination is safe and toler…
Phase 2 • Sponsor: PRG Science & Technology Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 09:03 UTC